Summary of Key Information:

Reporting Period (Quarter/Year): Quarter ended June 30, 2026 (Q1 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting and Unaudited Financial Results under SEBI LODR Regulations 30 and 33

Audit Opinion:

The Limited Review Report by Kulkarni & Khanolkar Chartered Accountants (Firm Reg. No. 105407W) expressed an unmodified opinion. Nothing came to their attention to believe the financial results contain any material misstatement.

Key Financial Highlights [All figures in ₹ Lakhs, except EPS]

Standalone Results:

  • Revenue from Operations: ₹36,731.00 (Q1 FY27) vs ₹27,094.39 (Q1 FY26) — a 35.6% YoY increase
  • Total Income: ₹36,875.00 (Q1 FY27) vs ₹31,689.98 (Q4 FY26) — a 16.4% QoQ increase
  • Net Profit: ₹3,062.76 (Q1 FY27) vs ₹2,548.63 (Q1 FY26) — a 20.2% YoY increase
  • EPS: Basic and Diluted ₹4.17 (Q1 FY27) vs ₹3.48 (Q1 FY26)
  • Other Comprehensive Income: (₹44.54)
  • Total Comprehensive Income: ₹3,029.43

Consolidated Results:

  • Revenue from Operations: ₹37,464.03 (Q1 FY27) vs ₹31,760.61 (Q4 FY26) — a 17.9% QoQ increase
  • Total Income: ₹37,608.14 (Q1 FY27) vs ₹32,350.34 (Q4 FY26)
  • Net Profit: ₹3,075.50 (Q1 FY27) vs ₹2,050.69 (Q4 FY26) — a 50.0% QoQ increase
  • Total Comprehensive Income: ₹3,042.17
  • Total Comprehensive Income Attributable to Owners of the Company: ₹2,990.01
  • Total Comprehensive Income Attributable to Non-Controlling Interest: ₹52.16
  • EPS: Basic and Diluted ₹4.19 (Q1 FY27) vs ₹2.73 (Q4 FY26)

Expenses Breakdown (Standalone):

  • Cost of Materials Consumed: ₹25,836.33
  • Purchase of Stock in Trade: ₹512.99
  • Changes in inventories: (₹2,140.41)
  • Employee benefits expenses: ₹1,682.30
  • Finance costs: ₹608.91
  • Depreciation and amortisation: ₹613.63
  • Other Expenses: ₹5,656.73
  • Total Expenses: ₹32,770.48

Tax Expense (Standalone):

  • Current Tax: ₹1,021.31
  • Deferred Tax: ₹20.45

Corporate Actions:

The Board of Directors recommended a payment of final dividend of ₹0.50 per equity share of the face value of ₹5/- each for the financial year ended 31st March 2026. The payment is subject to the approval of shareholders in the ensuing Annual General Meeting.

Other Significant Information:

  • The company operates primarily in one business segment: manufacturing of Chemicals.
  • The figures for the quarter ended March 31, 2026 (Q4 FY26) are audited.
  • The consolidated results include the following subsidiaries:

1. Indo Specialty Chemicals Pvt Ltd. (Formerly Ashok Surfactant Pvt Ltd) (39.39% Holding)

2. Indo Amines Americas LLC

3. Indo Amines (Europe) Ltd

4. Indo Amines (Changzhou) Co Ltd

5. Indo Amines (Malaysia) SDN BHD.

  • The review report notes that the interim financial information of four foreign subsidiaries (Indo Amines (Malaysia) SDN BHD, Indo Amines Americas LLC, Indo Amines (Changzhou) Co Ltd, Indo Amines (Europe) Ltd) was unaudited and provided by management. These subsidiaries had total assets of ₹9,147.67 Lakhs and total revenues of ₹5,654.92 Lakhs as of 30th June 2026.
  • The review report also notes that the interim financial information of Indo Specialty Chemicals Private Ltd. was reviewed by other auditors.